This startup uses Artificial intelligence to crack down on fake products
NeuroTags says RFIDs and holograms are used extensively but can be replicated easily.
Share market update: Nifty Pharma index flat; Cadila Healthcare dips nearly 2%
Benchmark NSE Nifty50 index was up 14.80 points at 10,615.95 w...
Election anxiety, US-China tension pull stocks down
The BSE mid and small cap indices also fell 1.5 per cent and 1.4 per cent, respectively.
Buzzing stocks: RCom, Sun Pharma, Vakrangee, YES Bank, Maruti Suzuki
The NSE Nifty index was trading 99.5 points down at 10,683.4, while BSE Sensex was down 283.2 points at 35,601.21 around 09:39 am on Thursday.
Sensex slips nearly 300 points, Nifty50 below 10,700 amid weak global cues
Sensex and Nifty extended losses to the third consecutive session.
Share market update: Pharma shares in the red; Lupin, Sun Pharma top losers
Benchmark NSE Nifty50 index was down 63.90 points at 10,805.6 while BSE Sensex was down 182.73 points at 35,951.58 around 12:41 pm.
Bollywood, Beyoncé and bling: Theme of India's big, fat Isha-Anand wedding
Priyanka Chopra, who got married last week, will also join the Ambanis for the grand celebration.
Policy pause fails to cheer D-Street, Nifty loses 87 points
Money managers said the market fall was largely due to weakness in global markets.
Share market update: Pharma shares trade lower; Sun Pharma plunges over 8%
Benchmark NSE Nifty50 index was down 26.75 points at 10,850 while BSE Sensex was down 77.07 points at 36,117.23.
Too many shadows on Sun: What's really happening at India's largest pharma company
Sun Pharma's stock tumbled to 6-month low after various allegations of misgovernance and insider trading.
Buzzing stocks: YES Bank, Sun Pharma, Tata Steel, Maruti Suzuki
The NSE Nifty index was trading 44.45 points up at 10,921.2, while BSE Sensex was up 177.42 points at 36,371.72 around 10:17 am on Monday.
What changed your markets while you were sleeping
The Nifty50 rose for the sixth consecutive session on Monday but showed signs of fatigue.
Sun Pharma open to evaluating past decisions: Dilip Shanghvi
A WhatsApp forward leaked details of a report containing allegations of corporate governance improprieties
Sebi may reopen insider trading case against Sun Pharma
Alleged irregularities in raising funds through FCCBs are likely to be probed by the watchdog, said sources.
Sell Sun Pharmaceutical Industries, target Rs 545: Manas Jaiswal
Sell Sun Pharmaceutical Industries Ltd. at a price target of Rs 545.0 and a stoploss at Rs 593 from entry point.